| CAS ID: | 186826-86-8 |
| Molecular Formula: | C21H25ClFN3O4 |
| Molecular Weight: | 401.4 g/mol |
| Monoisotopic Mass: | 401.1751 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | MOXIFLOXACIN HYDROCHLORIDE | BAY-12-8039 | VIGAMOX | MOXEZA | BAY 12-8039 | AVELOX |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1 | See All |
| InChI Key: | IDIIJJHBXUESQI-DFIJPDEKSA-N | |
| Smiles: | Cl.COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01910415 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | July 29, 2013 | Last Verified | August 11, 2014 |
| Sponsor | Vertex Pharmaceuticals Incorporated | ||
| PubChem: | 101526 |
| ChEMBL: | CHEMBL1200735 |